Bone Morphogenetic Protein Market 2028 By Type - 2, Application, End User and Geography | The Insight Partners

report image

Bone Morphogenetic Protein Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2, Recombinant Human Bone Morphogenetic Protein (rhBMP) -7, Bone morphogenetic protein 4); Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial); End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Academic Research, Others) and Geography

Report Code: TIPRE00006919 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Bone morphogenetic proteins (BMPs) are growth factors that belongs to the transforming growth factor beta (TGF- beta) superfamily. Bone Morphogenetic Protein 2, a member of the TGF- beta superfamily of cytokines, has been shown in several studies to inhibit the proliferation of human breast cancer cells. During embryogenesis, it is also involved in the production of bone and cartilage, as well as skeletal development. The key driving factors for the bone morphogenetic protein market are, rising incidences of spinal injuries along with extensive R&D activities for development of effective BMP Therapies.


The "Global Bone Morphogenetic Protein Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the bone morphogenetic protein market with detailed market segmentation by type, application and end user. The report provides key statistics on the market status of the leading bone morphogenetic protein market players and offers key trends and opportunities in the market.


  •   Based on type the market is segmented as, recombinant human bone morphogenetic protein (rhBMP) - 2, recombinant human bone morphogenetic protein (rhBMP) -7, bone morphogenetic protein 4.
  •   Based on application the market is segmented as, spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial.
  •   Based on end user the market is segmented as, hospitals, specialty clinics, ambulatory surgery centers, academic research, and others.


  •   Rising incidences of spinal injuries and growing geriatric population across the globe.
  •   Rising applications of morphogenetic proteins along with the benefits offered by morphogenetic proteins as compared to other bone grafting procedures.
  •   Extensive R&D activities for development of effective BMP therapies for management of disorders.


  •   However, off-label use of BMP, product recalls due to reported adverse events, and restricted FDA approval are all limiting factors for the bone morphogenetic protein market.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The bone morphogenetic protein market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the bone morphogenetic protein market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the bone morphogenetic protein market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from bone morphogenetic protein market are anticipated to lucrative growth opportunities in the future with the rising demand for bone morphogenetic protein in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the bone morphogenetic protein market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Medtronic
  •   Merck KGaA
  •   Stryker Corporation
  •   Thermo Fischer Scientific
  •   DePuy Synthes (Johnson and Johnson)
  •   Ember Therapeutics
  •   Integra LifeSciences
  •   R and D Systems
  •   Smith and Nephew
  •   Zimmer Biomet Holdings, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Medtronic
2. Merck KGaA
3. Stryker Corporation
4. Thermo Fischer Scientific
5. DePuy Synthes(Johnson and Johnson)
6. Ember Therapeutics
7. Integra LifeSciences
8. R and D Systems
9. Smith and Nephew
10. Zimmer Biomet Holdings, Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount